Randomized phase 3 study of a novel, long-acting G-CSF (SPI-2012) versus pegfilgrastim in the management of chemotherapy-induced neutropenia in early-stage breast cancer patients receiving docetaxel and cyclophosphamide (TC) (ADVANCE study)

被引：0

作者：

Schwartzberg, L.

Vacirca, J. L.

Hager, S. J.

Adoo, C. S.

Ibrahim, E. N.

Bhat, G.

Choi, M. R.

Allen, L. F.

Tedesco, K. L.

Agajanian, R.

机构：

[1] West Clin, Memphis, TN USA

[2] North Shore Hematol Oncol Associates, East Setauket, NY USA

[3] Calif Canc Associates Res & Excellence, Fresno, CA USA

[4] Arizona Ctr Canc Care, Glendale, AZ USA

[5] Beaver Med Grp, Highland, CA USA

[6] Spectrum Pharmaceut, Irvine, CA USA

[7] McKesson Specialty Hlth, New York Oncol Hematol US Oncol, Albany, NY USA

[8] Oncol Inst Hope & Innovat, Downey, CA USA

来源：

关键词：

D O I：

10.1158/1538-7445.SABCS15-OT3-02-13

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OT3-02-13

引用

页数：2